503 related articles for article (PubMed ID: 19702679)
21. Long-term clinical follow-up after sirolimus-eluting stent versus bare metal stent implantation in patients with acute coronary syndrome.
Ogita M; Nakamura T; Fujiwara N; Sakakura K; Funayama H; Sugawara Y; Kubo N; Ako J; Momomura S
J Interv Cardiol; 2009 Jun; 22(3):216-21. PubMed ID: 19490360
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels.
Kronsteiner E; Lee RW; Sweeney JP; Metallo JR; Stoehr JD; Fortuin FD
J Invasive Cardiol; 2010 Feb; 22(2):76-9. PubMed ID: 20124593
[TBL] [Abstract][Full Text] [Related]
24. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry.
Williams DO; Abbott JD; Kip KE;
Circulation; 2006 Nov; 114(20):2154-62. PubMed ID: 17060386
[TBL] [Abstract][Full Text] [Related]
27. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
Das P; Moliterno DJ; Charnigo R; Mukherjee D; Steinhubl SR; Sneed JD; Booth DC; Ziada KM
J Invasive Cardiol; 2006 Sep; 18(9):405-8. PubMed ID: 16954577
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry.
Bezerra H; Perin E; Berger P; Block P; Ramee S; Katz S; Kellet M; Dippel E; Schaer G; Britto S; Cohen S; Costa M
J Invasive Cardiol; 2010 Feb; 22(2):48-55. PubMed ID: 20124586
[TBL] [Abstract][Full Text] [Related]
29. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C
Cardiology; 2008; 111(4):270-6. PubMed ID: 18451644
[TBL] [Abstract][Full Text] [Related]
30. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.
Jeong YH; Hong MK; Lee CW; Park DW; Kim YH; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2008 Mar; 125(1):36-40. PubMed ID: 17521753
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).
Harjai KJ; Orshaw P; Shenoy C; Acharji S; Sporn D; Aboufares A; Stapleton D
J Interv Cardiol; 2008 Aug; 21(4):315-24. PubMed ID: 18754967
[TBL] [Abstract][Full Text] [Related]
32. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.
Minutello RM; Bhagan S; Sharma A; Slotwiner AJ; Feldman DN; Cuomo LJ; Wong SC
J Interv Cardiol; 2007 Dec; 20(6):458-65. PubMed ID: 18042050
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.
Han YL; Zhang J; Li Y; Wang SL; Jing QM; Yi XH; Ma YY; Luan B; Wang G; Wang B
Chin Med J (Engl); 2009 Mar; 122(6):643-7. PubMed ID: 19323927
[TBL] [Abstract][Full Text] [Related]
34. Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction.
Newell MC; Henry CR; Sigakis CJ; Unger BT; Larson DM; Chavez IJ; Burke MN; Traverse JH; Henry TD
Am J Cardiol; 2006 May; 97(9):1299-302. PubMed ID: 16635599
[TBL] [Abstract][Full Text] [Related]
35. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
[TBL] [Abstract][Full Text] [Related]
36. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
37. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
[TBL] [Abstract][Full Text] [Related]
38. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
[TBL] [Abstract][Full Text] [Related]
39. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
[TBL] [Abstract][Full Text] [Related]
40. Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.
Ong AT; van Domburg RT; Aoki J; Sonnenschein K; Lemos PA; Serruys PW
J Am Coll Cardiol; 2006 Apr; 47(7):1356-60. PubMed ID: 16580521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
